• 1
    Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men [see comments]. J Urol 1994; 151: 1283-90.
  • 2
    Labrie F, Dupont A, Suburu R, Cusan L, Gomez JL, Koutsilieris M, et al. Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen. Clin Invest Med 1993; 16 (6): 425-39.
  • 3
    Andriole GL, Catalona WJ. Using PSA to screen for prostate cancer. The Washington University experience. Urol Clin North Am 1993; 20: 647-51.
  • 4
    Babaian RJ, Mettlin C, Kane R, Murphy GP, Lee F, Drago JR, et al. The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography. Findings of the American Cancer Society National Prostate Cancer Detection Project. Cancer 1992; 69: 1195-200.
  • 5
    Mettlin C, Murphy GP, Ray P, Shanberg A, Toi A, Chesley A, et al. American Cancer Society--National Prostate Cancer Detection Project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigen. Cancer 1993; 71: 891-8.
  • 6
    Lee F, Littrup PJ, Torp-Pedersen ST, Mettlin C, McHugh TA, Gray JM, et al. Prostate cancer: comparison of transrectal US and digital rectal examination for screening. Radiology 1988; 168: 389-94.
  • 7
    Mettlin C, Murphy GP, Lee F, Littrup PJ, Chesley A, Babain R, et al. Characteristics of prostate cancers detected in a multimodality early detection program. Cancer 1993; 72 (5): 1701-6.
  • 8
    Humphrey PA, Keetch DW, Smith DS, Shepherd DL, Catalona WJ. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. J Urol 1996; 155:(3) 816-20.
  • 9
    Schmid HP, Stamey TA, McNeal JE, Freiha FS, Redwine EA, Whittemore AS. Effect of the natural history on management of adenocarcinoma of the prostate. Urologe A 1994; 33:(2) 144-8.
  • 10
    Noldus J, Stamey TA. Histological characteristics of radical prostatectomy specimens in men with a serum prostate specific antigen of 4 ng/ml or less. J Urol 1996; 155:(2) 441-3.
  • 11
    Stamey TA, Freiha FS, McNeal FE, Redwine EA, Whittemore AS, Schmid HP. Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993; 71 (3): 933-52.
  • 12
    McNeal JE, Bostwick DG, Kindrachuk RA, Redwine EA, Freiha FS, Stamey TA. Patterns of progression in prostate cancer. Lancet 1986; 1: 60-3.
  • 13
    Mettlin C, Murphy GP, Babaian RJ, Chesley A, Kane RA, Littrup PJ, et al. The results of a five-year early prostate cancer detection intervention. Cancer 1996; 77: (1)150-9.